SCHEMBL20443289

SCHEMBL20443289

CCC(C)(C)OCCOCCOCCOCCOCC(=O)NC(C)(C)C

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 1/20 0.36
ALDH1A1 P00352 4/20 0.35
LMNA P02545 4/20 0.35
MAPT P10636 3/20 0.35
NPC1 O15118 2/20 0.35
CASP3 P42574 1/20 0.35
SENP8 Q96LD8 1/20 0.35
SENP7 Q9BQF6 1/20 0.35
SENP6 Q9GZR1 1/20 0.35
POLB P06746 1/20 0.35
KMT2A Q03164 3/20 0.34
HTT P42858 2/20 0.34
MEN1 O00255 2/20 0.34
HPGD P15428 1/20 0.34
CYP1A2 P05177 1/20 0.34
CYP3A4 P08684 1/20 0.34
CYP2C19 P33261 1/20 0.34
SMN1; SMN2 Q16637 4/20 0.33
L3MBTL1 Q9Y468 1/20 0.32
TP53 P04637 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20128740 0.84 TSHR (0.38) TSHRALDH1A1LMNAMAPTNPC1
SCHEMBL26158875 0.84 TSHR (0.38) TSHRALDH1A1LMNAMAPTNPC1
SCHEMBL20436938 0.84 TSHR (0.38) TSHRALDH1A1LMNAMAPTNPC1
SCHEMBL21935318 0.84 TSHR (0.34) TSHRALDH1A1LMNAMAPTNPC1
SCHEMBL26158859 0.82 TSHR (0.39) TSHRALDH1A1LMNAMAPTNPC1
SCHEMBL22005980 0.79 KMT2A (0.42) TSHRALDH1A1LMNAMAPTNPC1
SCHEMBL26972566 0.78 TSHR (0.41) TSHRALDH1A1LMNAMAPTNPC1
SCHEMBL12234226 0.77 TSHR (0.38) TSHRALDH1A1LMNAMAPTNPC1
SCHEMBL13996787 0.77 CES2 (0.42) TSHRALDH1A1LMNAMAPTNPC1
SCHEMBL13234037 0.77 TSHR (0.40) TSHRALDH1A1LMNAMAPTNPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230183209-A1 CEREBLON LIGANDS AND BIFUNCTIONAL COMPOUNDS COMPRISING THE SAME ARVINAS OPERATIONS, INC. (US) 2023-06-15 US disclosed
US-20180215731-A1 CEREBLON LIGANDS AND BIFUNCTIONAL COMPOUNDS COMPRISING THE SAME ARVINAS OPERATIONS, INC. 2018-08-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230183209-A1 CEREBLON LIGANDS AND BIFUNCTIONAL COMPOUNDS COMPRISING THE SAME CRBN, CBL, MDM2 TSHR 3772/4885ALDH1A1 3671/4885LMNA 3085/4885
US-20180215731-A1 CEREBLON LIGANDS AND BIFUNCTIONAL COMPOUNDS COMPRISING THE SAME CRBN, CBL, MDM2 TSHR 3772/4885ALDH1A1 3671/4885LMNA 3085/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.